ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • Register
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 62

CCR6+CD4+ T Cells Drive IL-23R Signaling-Dependent Progression of Antigen-Induced Arthritis

W Razawy1, N Salioska2, P Asmawidjaja3, A Otten-Mus4, N Kops5, M Oukka6, V Kuchroo7 and Erik Lubberts3, 1Rheumatology and Immunology, Erasmus MC, Rotterdam, Netherlands, 2Rheumatology, Erasmus MC, Rotterdam, Netherlands, 3Rheumatology and Immunology, Erasmus MC, University Medical Center, Rotterdam, Netherlands, 4Immunology, Erasmus MC, University Medical Center, Rotterdam, Netherlands, 5Orthopedics, Erasmus MC, Rotterdam, Netherlands, 6Pediatrics, Seattle Children's Research Institute, Seattle, WA, 7Center for Neurologic Diseases, Harvard Institute of Medicine, Boston, MA

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Arthritis, cytokines and inflammation, IL-23, T cells

  • Tweet
  • Email
  • Print
Save to PDF
Session Information

Date: Sunday, October 21, 2018

Session Title: Rheumatoid Arthritis – Animal Models Poster

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: The IL-23/IL-17A immune pathway is important for the progression of T cell-mediated arthritis. However, it is not known where IL-23R+ T cells locate during the different stages of arthritis and which IL-23R+ T cells drive joint inflammation. We aimed to identify IL-23R+ T cells in the secondary lymphoid organs during the development and progression of antigen-induced arthritis (AIA). Furthermore, we studied which IL-23R+ T cells drive full-blown AIA.

Methods: To induce AIA, IL-23R+/+ (WT), heterozygous IL-23R+/GFP, and IL-23RGFP/GFP (IL-23RKO) mice were immunized with methylated bovine serum albumin (mBSA) in Complete Freund’s Adjuvant. After 7 days mice were injected in the knee joints with mBSA. Mice were macroscopically scored at different time points and knees were used for histological analysis of the joints. The spleen, inguinal and popliteal lymph nodes (LN) were collected and analyzed for the expression of GFP+/IL-23R+ T cells. To study which T cells drive AIA, CCR6+CD4+ T cells and γδ T cells from CFA/mBSA immunized WT mice were adoptively transferred into IL-23RKO recipient mice prior to AIA induction and disease severity was assessed at the peak of AIA.

Results: AIA disease progression was mainly driven by the IL-23R pathway since IL-23RKO mice had significantly lower arthritis scores and less bone damage. Furthermore, the fraction and total CD4+ and TCRγδ+ cell counts were lower in IL-23RKO joints at day 4 of AIA. In vitro, cells of IL-23RKO mice produced less IL-17A. Heterozygous IL-23R reporter mice had similar disease scores to WT mice, indicating that half of the receptor expression is sufficient to drive disease. Flow cytometric analysis of GFP/IL-23R in T cells of naïve and arthritic IL-23R reporter mice revealed that a fraction of CCR6+CD4+ T cells and γδ T cells, but not CD8+ T cells, expressed IL-23R in the lymphoid tissues. Already one day after arthritis induction, the fraction IL-23R+ CCR6+CD4+ T cells was increased in the draining LNs from the joints. The fraction of these IL-23R+ T cells decreased gradually during the progression of disease, possibly due to their migration towards the synovium. Adoptively transferred CCR6+CD4+ T cells, but not γδ T cells, were able

Conclusion: The IL-23R signaling pathway is essential for full-blown AIA. CCR6+CD4+ T cells and γδ T cells, but not CD8+ T cells, express IL-23R during naïve and inflammatory conditions. Interestingly, adoptive transfer of CCR6+CD4+ T cells but not γδ T cells, can rescue arthritis in IL-23R deficient mice.


Disclosure: W. Razawy, None; N. Salioska, None; P. Asmawidjaja, None; A. Otten-Mus, None; N. Kops, None; M. Oukka, None; V. Kuchroo, None; E. Lubberts, None.

To cite this abstract in AMA style:

Razawy W, Salioska N, Asmawidjaja P, Otten-Mus A, Kops N, Oukka M, Kuchroo V, Lubberts E. CCR6+CD4+ T Cells Drive IL-23R Signaling-Dependent Progression of Antigen-Induced Arthritis [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 10). https://acrabstracts.org/abstract/ccr6cd4-t-cells-drive-il-23r-signaling-dependent-progression-of-antigen-induced-arthritis/. Accessed January 27, 2021.
  • Tweet
  • Email
  • Print
Save to PDF

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/ccr6cd4-t-cells-drive-il-23r-signaling-dependent-progression-of-antigen-induced-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Convergence: Where Rheumatology Meets. All Virtual. November 5-9.

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2021 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.